ID: ALA2392835

Max Phase: Preclinical

Molecular Formula: C25H33N5O3S

Molecular Weight: 483.64

Molecule Type: Small molecule

Representations

Canonical SMILES:  CS(=O)(=O)C1CCN(c2cccc3c2ccn3-c2ccnc(N[C@H]3CC[C@@](C)(O)CC3)n2)CC1

Standard InChI:  InChI=1S/C25H33N5O3S/c1-25(31)12-6-18(7-13-25)27-24-26-14-8-23(28-24)30-17-11-20-21(4-3-5-22(20)30)29-15-9-19(10-16-29)34(2,32)33/h3-5,8,11,14,17-19,31H,6-7,9-10,12-13,15-16H2,1-2H3,(H,26,27,28)/t18-,25+

Standard InChI Key:  GZFOTMBQLVXWAV-HMRCJKRNSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 483.64

Molecular Weight (Monoisotopic): 483.2304

AlogP: 3.54

#Rotatable Bonds: 5

Polar Surface Area: 100.35

Molecular Species: NEUTRAL

HBA: 8

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 6.09

CX LogP: 2.42

CX LogD: 2.40

Aromatic Rings: 3

Heavy Atoms: 34

QED Weighted: 0.57

Np Likeness Score: -0.64

References

1. Gong L, Han X, Silva T, Tan YC, Goyal B, Tivitmahaisoon P, Trejo A, Palmer W, Hogg H, Jahagir A, Alam M, Wagner P, Stein K, Filonova L, Loe B, Makra F, Rotstein D, Rapatova L, Dunn J, Zuo F, Dal Porto J, Wong B, Jin S, Chang A, Tran P, Hsieh G, Niu L, Shao A, Reuter D, Hermann J, Kuglstatter A, Goldstein D..  (2013)  Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.,  23  (12): [PMID:23664880] [10.1016/j.bmcl.2013.04.029]

2.  (2013)  Inhibitors of JNK, 

Source

Source(2):

• Scientific Literature
• BindingDB Database